We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
208 hedge funds and large institutions have $1.03B invested in Corcept Therapeutics in 2019 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 60 increasing their positions, 78 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
2.57% less ownership
Funds ownership: 78.8% → 76.24% (-2.6%)
6% less funds holding
Funds holding: 222 → 208 (-14)
15% less capital invested
Capital invested by funds: $1.22B → $1.03B (-$188M)
23% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 78
29% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 41
39% less call options, than puts
Call options by funds: $5M | Put options by funds: $8.24M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
208
Holders Change
-14
Holders Change %
-6.31%
% of All Funds
4.5%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
29
Increased
60
Reduced
78
Closed
41
Calls
$5M
Puts
$8.24M
Net Calls
-$3.24M
Net Calls Change
+$862K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$5.1M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.02M |
| 3 |
BlackRock
New York
|
+$3.97M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.55M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.53M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$30.6M |
| 2 |
D.E. Shaw & Co
New York
|
-$6.44M |
| 3 |
Morgan Stanley
New York
|
-$5.63M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$5.39M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.32M |
